1-(3-Nitropyridin-2-yl)piperidine-4-carbonitrile

Catalog No. :
ACPPLN900
CAS No. :
671191-99-4
Molecular Formula :
C11H12N4O2
Molecular Weight :
232.24

IUPAC Name:1-(3-nitropyridin-2-yl)piperidine-4-carbonitrile

1-(3-Nitropyridin-2-yl)piperidine-4-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$228.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-Nitropyridin-2-yl)piperidine-4-carbonitrile
IUPAC Name1-(3-nitropyridin-2-yl)piperidine-4-carbonitrile
MDL No.MFCD00106383
Molecular FormulaC11H12N4O2
Molecular Weight232.24
SMILESN#CC1CCN(C2=NC=CC=C2[N+]([O-])=O)CC1
InChI KeyUEXODVNTPRVAEL-UHFFFAOYSA-N
Synonym2-(4-Cyanopiperidin-1-yl)-3-nitropyridine;2-(4-Cyanopiperidin-1-yl)-3-nitropyridine, 4-Cyano-1-(3-nitropyridin-2-yl)piperidine;1-(3-Nitropyridin-2-yl)piperidine-4-carbonitrile 95+%;4-Piperidinecarbonitrile, 1-(3-nitro-2-pyridinyl)-
CAS No.671191-99-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPPLN900 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIYJR681 route compound structure diagram
    ACIYJR6814395-98-6 In Stock
  2. Plus
  3. ACBXKI483 route compound structure diagram
    ACBXKI4835470-18-8 In Stock
  4. Then
  5. ACPPLN900 route product structure diagram
    ACPPLN900671191-99-4
Inquiry

2. ACPPLN900 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIYJR681 route compound structure diagram
    ACIYJR6814395-98-6 In Stock
  2. Plus
  3. ACPBYK143 route compound structure diagram
    ACPBYK14319755-53-4 In Stock
  4. Then
  5. ACPPLN900 route product structure diagram
    ACPPLN900671191-99-4
Inquiry

Comments (0)